Replay available

Ocular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call

Ocular Therapeutix, Inc. (NASDAQ: OCUL) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.

Tue, May 5, 2026 at 8:00 AMendedReplay
Ocular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call

Hosted by

Featured presenters

Lisa Walter

RBC Capital Markets Analyst

Fazeen Ahmed

Bank of America Analyst

Truman Dunkley

William Blair Analyst

Bill Slattery Jr.

Vice President, Investor Relations

Dr. Praveen Dougal

Executive Chairman, President & CEO

Sanjay Nayak

Chief Strategy Officer

Sean McCutcheon

Raymond James Analyst

Yin Chin

HC Wainwright Analyst

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ocular Therapeutix, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.477 Thank you for your continued patience. Your meeting will begin shortly. 00:00:03.477 -- 00:00:08.244 If you need assistance at any time, please press star zero and a member of our team will 00:00:08.244 -- 00:00:10.945 be happy to help you. 00:00:25.242 -- 00:00:27.242 ¶¶ 00:01:30.262 -- 00:01:32.603 Thank you. 00:01:47.508 -- 00:01:50.349 © transcript 00:02:03.334 -- 00:02:05.854 Emily Beynon 00:02:15.200 -- 00:02:17.200 © 00:02:17.342 -- 00:02:19.342 transcript 00:02:32.958 -- 00:02:35.919 Emily Beynon 00:02:40.630 -- 00:02:42.630 ¶¶ 00:03:10.938 -- 00:03:12.938 ¶¶ 00:03:41.195 -- 00:03:43.195 ¶¶ 00:04:12.329 -- 00:04:17.777 Good morning and welcome to the Ocular Therapeutics first quarter 2026 earnings 00:04:17.777 -- 00:04:23.246 conference call. At this time, all participants are in a listen-only mode. 00:04:23.246 -- 00:04:27.292 After the prepared remarks, we will conduct a question and answer session. 00:04:27.292 -- 00:04:31.158 If you would like to ask a question, please press star 1 on your telephone. 00:04:31.158 -- 00:04:32.580 As 00:04:32.580 -- 00:04:37.248 a reminder, this conference call is being recorded and will be available for replay on 00:04:37.248 -- 00:04:41.860 the investor relations section of the Ocular Therapeutics website. 00:04:41.860 -- 00:04:46.145 I would now like to turn the call over to Ocular's Vice President of Investor Relations, 00:04:46.145 -- 00:04:50.507 Bill Slattery, Jr. Please go ahead, Mr. Slattery. 00:04:50.709 -- 00:04:53.873 Good morning, everyone, and thank you for joining us today. 00:04:53.873 -- 00:04:58.578 Earlier this morning, we issued a press release and filed our quarterly report on Form 00:04:58.578 -- 00:05:05.305 10-Q, outlining our financial results and business updates...